| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $32,182,371 ) (Continued on the next page) |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01NS116037 | Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma | 000 | 4 | NIH | 11/7/2023 | $360,639 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL155439 | GATA Factor Mechanisms in Erythroid Regeneration | 000 | 4 | NIH | 12/18/2023 | $383,750 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA241752 | Targeting MUC5AC mucin in breast cancer brain metastasis | 000 | 4 | NIH | 1/16/2024 | $415,170 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA241752 | Targeting MUC5AC mucin in breast cancer brain metastasis | 001 | 4 | NIH | 4/16/2024 | $23,065 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA290859 | Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer | 000 | 1 | NIH | 3/18/2024 | $621,119 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL171602 | Nrf2 and the exaggerated Exercise Pressor Reflex in Peripheral Arterial Disease | 000 | 1 | NIH | 12/11/2023 | $564,745 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T32GM152836 | Medical Scientist Training Program at the University of Nebraska | 000 | 1 | NIH | 3/18/2024 | $125,935 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK119337 | Mechanisms of iron-mediated renal injury in lupus nephritis | 000 | 5 | NIH | 1/29/2024 | $301,950 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P20GM130447 | Cognitive Neuroscience of Development and Aging (CONDA) Center | 001 | 5 | NIH | 3/25/2024 | $2,051,793 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA244900 | The Role of the CBFB-MYH11 Complex in Leukemia Maintenance | 001 | 5 | NIH | 4/16/2024 | $19,039 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA244900 | The Role of the CBFB-MYH11 Complex in Leukemia Maintenance | 000 | 5 | NIH | 3/12/2024 | $342,663 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | H7600529 | Ryan White Part C Outpatient EIS Program | 01 | 25 | HRSA | 1/26/2024 | $234,376 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | H7600529 | Ryan White Part C Outpatient EIS Program | 00 | 25 | HRSA | 11/15/2023 | $175,783 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA239688 | Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations | 001 | 5 | NIH | 4/17/2024 | $17,443 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA239688 | Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon Mutations | 000 | 5 | NIH | 12/7/2023 | $313,959 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | Omaha | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 01 | 14 | HRSA | 4/16/2024 | $393,960 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | U0117261 | Partnership for Urban MCH Leadership Community | 00 | 14 | HRSA | 3/13/2024 | $306,040 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R00GM138920 | Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes | 001 | 4 | NIH | 3/7/2024 | $224,101 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21CA273399 | Targeting RHNO1 in Ovarian Cancer | 001 | 2 | NIH | 4/17/2024 | $10,765 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21CA273399 | Targeting RHNO1 in Ovarian Cancer | 000 | 2 | NIH | 3/20/2024 | $193,755 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R21AI171228 | Characterizing the Function of the Periplasmic Protease Tsp in Chlamydial Secondary Differentiation | 000 | 2 | NIH | 1/30/2024 | $169,988 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL163043 | Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury | 000 | 3 | NIH | 2/8/2024 | $418,203 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F31CA271724 | Oncogenic insults within the pancreatic ductal glands produce pre-malignant lesions and PDAC | 000 | 2 | NIH | 3/12/2024 | $37,838 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01MH132517 | PREVENTING ALZHEIMER?S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5 | 000 | 2 | NIH | 1/19/2024 | $621,673 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P50AA030407 | Alcohol Center Of Research -- Nebraska (ACORN) | 000 | 2 | NIH | 1/23/2024 | $1,588,725 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK135817 | Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice | 000 | 2 | NIH | 3/12/2024 | $366,218 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AR082148 | Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union | 000 | 2 | NIH | 1/10/2024 | $396,894 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R00AG059947 | Behavioral and physiological linkage in people with frontotemporal dementia and spousal caregivers | 001 | 5 | NIH | 1/4/2024 | $218,289 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU50CK000619 | Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States. | 05 | 2 | CDC | 3/5/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 Nebraska Medical Center | OMAHA | NE | 68198-7835 | DOUGLAS | USA | NU50CK000619 | Strengthening Healthcare Infection Prevention and Control and Improving Patient Safety in the United States. | 04 | 2 | CDC | 1/2/2024 | $2,720,000 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA255618 | Use of radioprotector in rectal cancer | 000 | 3 | NIH | 2/5/2024 | $1 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM145736 | Neuromuscular junction as a therapeutic target to improve post-traumatic outcomes | 000 | 3 | NIH | 3/20/2024 | $338,468 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM145647 | Deciphering the Enzymatic Mechanism of Superoxide Dismutase | 000 | 3 | NIH | 4/9/2024 | $388,244 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM144414 | Insight into the mechanism of action of the SSB interactome | 002 | 3 | NIH | 4/15/2024 | $0 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM144414 | Insight into the mechanism of action of the SSB interactome | 001 | 3 | NIH | 4/4/2024 | $281,202 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL160820 | Skeletal Muscle Nrf2: Exercise-Induced Cardiovascular Protection | 000 | 3 | NIH | 12/5/2023 | $466,635 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI169788 | T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection | 000 | 3 | NIH | 2/26/2024 | $522,732 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DK131990 | Gut bacterial metallophores in the development and severity of inflammatory bowel disease | 000 | 3 | NIH | 3/5/2024 | $592,565 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA260749 | UPR Activators for Cancer Therapy | 001 | 3 | NIH | 4/16/2024 | $17,557 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA260749 | UPR Activators for Cancer Therapy | 000 | 3 | NIH | 1/9/2024 | $316,018 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI162964 | Mechanisms of staphylococcal skin colonization | 000 | 3 | NIH | 3/1/2024 | $476,697 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01AI163042 | New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B | 000 | 3 | NIH | 2/23/2024 | $550,057 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01HL156952 | Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia | 000 | 3 | NIH | 11/6/2023 | $345,375 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01DE031272 | Biomimetic and Injectable Highly Porous Nanofiber Microsphere-based Platform for Alveolar Bone Regeneration | 000 | 3 | NIH | 3/27/2024 | $486,868 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM141232 | Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair | 000 | 3 | NIH | 3/20/2024 | $283,208 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA266759 | Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer | 001 | 3 | NIH | 4/16/2024 | $22,106 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA266759 | Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer | 000 | 3 | NIH | 1/3/2024 | $397,900 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA259080 | Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer | 001 | 3 | NIH | 4/16/2024 | $17,817 |
| | 2024 | 2024 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01CA259080 | Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer | 000 | 3 | NIH | 2/8/2024 | $320,687 |
|
